Advertisement

Topics

Venetoclax Combo Therapy Shows Promise in Pediatric Patients with R/R AML

20:00 EDT 13 Jun 2019 | Cancer Networks

Early data on the safety and tolerability of combination venetoclax and cytarabine or cytarabine/idarubicin were presented at ASCO 2019.

Original Article: Venetoclax Combo Therapy Shows Promise in Pediatric Patients with R/R AML

NEXT ARTICLE

More From BioPortfolio on "Venetoclax Combo Therapy Shows Promise in Pediatric Patients with R/R AML"

Advertisement
Quick Search
Advertisement
Advertisement